Vernakalant

Modify Date: 2024-01-02 23:19:00

Vernakalant structure	Common Name	Vernakalant
	CAS Number	794466-70-9	Molecular Weight	349.464
	Density	1.1±0.1 g/cm3	Boiling Point	479.0±45.0 °C at 760 mmHg
	Molecular Formula	C₂₀H₃₁NO₄	Melting Point	N/A
	MSDS	N/A	Flash Point	243.5±28.7 °C

Use of Vernakalant

Vernakalant(RSD-1235) is an investigational mixed ion channel blocker that can terminate acute atrial fibrillation (AF) in humans at 2 to 5 mg/kg and may be more atrial-selective than available agents; in treatment of antiarrhythmic.IC50 value:Target:

Name	(3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol
Synonym	More Synonyms

Description	Vernakalant(RSD-1235) is an investigational mixed ion channel blocker that can terminate acute atrial fibrillation (AF) in humans at 2 to 5 mg/kg and may be more atrial-selective than available agents; in treatment of antiarrhythmic.IC50 value:Target:
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel Research Areas >> Cardiovascular Disease
References	[1]. Dorian, Paul MD et al. The Effect of Vernakalant (RSD1235), an Investigational Antiarrhythmic Agent, on Atrial Electrophysiology in Humans. Journal of Cardiovascular Pharmacology:July 2007 - Volume 50 -Issue 1 - pp 35-40. [2]. Jodene Eldstrom et al. The Molecular Basis of High-Affinity Binding of the Antiarrhythmic Compound Vernakalant (RSD1235) to Kv1.5 Channels. Molecular Pharmacology December 2007 vol. 72 no. 6 1522-1534 [3]. Vernakalant. Too dangerous in atrial fibrillation.Prescrire Int. 2012 May;21(127):119-22. [4]. Blomstr?m-Lundqvist C, Blomstr?m P.Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity.Expert Opin Drug Saf. 2012 Jul;11(4):671-9. Epub 2012 May 26. [5]. Bash LD, Buono JL, Davies GM, Martin A, Fahrbach K, Phatak H, Avetisyan R, Mwamburi M.Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.Cardiovasc Drugs Ther. 2012 Apr;

Description

Related Catalog

Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel

Research Areas >> Cardiovascular Disease

References

[1]. Dorian, Paul MD et al. The Effect of Vernakalant (RSD1235), an Investigational Antiarrhythmic Agent, on Atrial Electrophysiology in Humans. Journal of Cardiovascular Pharmacology:July 2007 - Volume 50 -Issue 1 - pp 35-40.

[2]. Jodene Eldstrom et al. The Molecular Basis of High-Affinity Binding of the Antiarrhythmic Compound Vernakalant (RSD1235) to Kv1.5 Channels. Molecular Pharmacology December 2007 vol. 72 no. 6 1522-1534

[3]. Vernakalant. Too dangerous in atrial fibrillation.Prescrire Int. 2012 May;21(127):119-22.

[4]. Blomstr?m-Lundqvist C, Blomstr?m P.Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity.Expert Opin Drug Saf. 2012 Jul;11(4):671-9. Epub 2012 May 26.

[5]. Bash LD, Buono JL, Davies GM, Martin A, Fahrbach K, Phatak H, Avetisyan R, Mwamburi M.Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.Cardiovasc Drugs Ther. 2012 Apr;

Density	1.1±0.1 g/cm3
Boiling Point	479.0±45.0 °C at 760 mmHg
Molecular Formula	C₂₀H₃₁NO₄
Molecular Weight	349.464
Flash Point	243.5±28.7 °C
Exact Mass	349.225311
PSA	51.16000
LogP	2.40
Vapour Pressure	0.0±1.3 mmHg at 25°C
Index of Refraction	1.557

(3R)-1-(2-(3,4-...

CAS#:906802-36-6

~77%

Vernakalant

CAS#:794466-70-9

Literature: CARDIOME PHARMA CORP. Patent: WO2006/88525 A1, 2006 ; Location in patent: Page/Page column 118; 127-128 ;

N/A

CAS#:1370354-69-0

Vernakalant

CAS#:794466-70-9

Literature: ALPHORA RESEARCH INC.; GORIN, Boris; DIXON, Craig Edward; OUDENES, Jan; BEJAN, Elena Valentina; KINSMAN, Aaron Cleveland Patent: WO2012/40846 A1, 2012 ; Location in patent: Page/Page column 22-23 ;

(3R)-3-benzylox...

CAS#:795281-92-4

Vernakalant

CAS#:794466-70-9

Literature: ASTELLAS PHARMA INC. Patent: WO2006/75778 A1, 2006 ; Location in patent: Page/Page column 26-28 ;

3,4-Dimethoxyph...

CAS#:7417-21-2

Vernakalant

CAS#:794466-70-9

Literature: Limanto, John; Ashley, Eric R.; Yin, Jingjun; Beutner, Gregory L.; Grau, Brendan T.; Kassim, Amude M.; Kim, Mary M.; Klapars, Artis; Liu, Zhijian; Strotman, Hallena R.; Truppo, Matthew D. Organic Letters, 2014 , vol. 16, # 10 p. 2716 - 2719

UNII:1134E5H2KV

CAS#:822-87-7

Vernakalant

CAS#:794466-70-9

2-(3,4-dimethox...

CAS#:1360617-31-7

Vernakalant

CAS#:794466-70-9

(R)-1-((1R,2R)-...

CAS#:795282-03-0

Vernakalant

CAS#:794466-70-9

Literature: CARDIOME PHARMA CORP.; ROTH, Carol, J. Patent: WO2006/138673 A2, 2006 ; Location in patent: Page/Page column 49; 74-75 ;

N/A

CAS#:1370354-67-8

Vernakalant

CAS#:794466-70-9

Precursor 6
CAS#:906802-36-6 (3R)-1-(2-(3,4-... CAS#:795281-92-4 (3R)-3-benzylox... CAS#:7417-21-2 3,4-Dimethoxyph... CAS#:822-87-7 UNII:1134E5H2KV
CAS#:1360617-31-7 2-(3,4-dimethox... CAS#:795282-03-0 (R)-1-((1R,2R)-...
DownStream 0

(3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol

(1R,2R)-2-[(3R)-hydroxypyrrolidinyl]-1-(3,4-dimethoxyphenethoxy)cyclohexane

Kynapid

Vernakalant

3-Pyrrolidinol, 1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, (3R)-

Brinavess

(1R-{2R-[2-(3,4-dimethoxyphenyl)-ethoxy]-cyclohex-2-yl})-pyrrolidin-3R-ol

(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidin-3-ol

RSD 1235

(3R)-1-{(1R,2R)-2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl}-3-pyrrolidinol

1R-(2R-(2-(3,4-dimethoxy-phenyl)-ethoxy)-cyclohexyl)-pyrrolidin-3R-ol

Vernakalant [INN:BAN]

UNII-9G468C8B13

cc-484

Vernakalant [INN]

(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidinol

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: Vemakalant
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

Get all suppliers and price by the below link:

Vernakalant suppliers

Price: $436/10mg

Reference only. check more Vernakalant price

Vernakalant

Use of Vernakalant

Names

Vernakalant Biological Activity

Chemical & Physical Properties

Synthetic Route

Precursor & DownStream

Synonyms